Skip to content
OpenCapital
Get started

Edesa Biotech, Inc. EDSA Q1 2026 earnings

Reported May 14, 2026 · Before market open

Diluted EPS-$0.49Miss by $0.25
EPS estimate-$0.24

Next report

Aug 14, 2026 (in a month)
EPS estimate-$0.44

Versus estimates

Diluted EPS

Q1 2026-$0.49Miss by $0.25
Q4 2025-$0.28In lineQ3 2025-$0.32Miss by $0.05Q2 2025-$0.25Beat by $0.01Q1 2025-$0.30In lineQ4 2024-$0.48Miss by $0.17

Ask the moment Edesa Biotech, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Edesa Biotech, Inc. report Q1 2026 earnings?
Edesa Biotech, Inc. (EDSA) reported Q1 2026 earnings on May 14, 2026 before market open.
What were Edesa Biotech, Inc.'s Q1 2026 revenue and EPS?
Edesa Biotech, Inc. reported diluted EPS of $-0.49 for Q1 2026.
Did Edesa Biotech, Inc. beat estimates in Q1 2026?
EPS missed the consensus estimate of $-0.24 by $0.25.
How did Edesa Biotech, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS declined 63.3% from $-0.30.
Where can I find Edesa Biotech, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001171843-26-003429) and the 10-Q periodic report (0001171843-26-003433) directly on SEC EDGAR. The filing index links above go to sec.gov.